Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
This article reviews the publicly available safety data for brodalumab, an interleukin-17R inhibitor approved for chronic plaque psoriasis. Is its safety profile similar to other IL-17 antagonists?
This review focuses on five major skin conditions for which dietary change may contribute to treatment--both by eliminating "triggers" and providing benefit.
Review new developments in therapy for hereditary angioedema, including new C1 inhibitors, and the development of drugs that target the kallikrein-kinin pathway.
A recent trial assessed the effects of azelaic acid 15% gel on inflammatory lesions of papulopustular rosacea in a real-world setting, with promising results.
